Products & ReviewLife Sciences

Alissa Clinical Informatics Platform

Agilent TechnologiesAvailable: Worldwide

Unlock the full potential of molecular diagnostics on a single platform

Request Pricing
Agilent Technologies

Receive your quote directly from the manufacturer.

Ease of Use
After Sales Service
Value for Money
Be the first to leave a review
Description

Alissa Clinical Informatics Platform delivers innovative NGS and CGH data analysis, variant interpretation and reporting modules designed to optimize workflows across technologies and applications. On the platform, integrate read alignment to reporting for greater efficiency. Interpret NGS and CGH data on a single sample to call CNVs via NGS data and run arrays as NGS tests for greater diagnostic yield. Shorten time to results by seamlessly flowing from raw data alignment, to annotations, to mutation categorization.

Application NoteClinical Diagnostics

Supporting clinical labs with new EU IVDR regulation

Citing a desire for improved patient safety and significant technological advances in recent years, the European Commission (EC) replaced the In Vitro Diagnostic Directive (IVDD) with a new, harmonized regulatory framework: the In Vitro Diagnostic Regulation (IVDR) (EU) 2017/746. Here, Agilent shows how it aims to support you and your clinical lab through this regulatory transition.


Product Overview

Links

Buy Alissa Clinical Informatics Platform Read Reviews